Trial Profile
A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of Hib-DTP vaccine, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2011
Price :
$35
*
At a glance
- Drugs Hib-DTP vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- 24 Oct 2011 New trial record